Compared to APOE ε4 noncarriers, APOE ε4 carriers had slower cognitive decline in general cognitive function (MMSE, and CDR-SB, P = .009 and 0.019), language (P = .017), memory (P = .011), and frontal-executive function (P = .001). This evidence concerns the gene APOE and Mental deterioration.